openPR Logo
Press release

Ankylosing Spondylitis Treatment Market Projected to Reach USD 10.39 Billion by 2030, as Oral and Biosimilar Therapies Gain Traction

08-10-2025 05:18 PM CET | Health & Medicine

Press release from: Mordor Intelligence

Ankylosing Spondylitis Treatment Market Size & Trends | Mordor Intelligence

Ankylosing Spondylitis Treatment Market Size & Trends | Mordor Intelligence

Mordor Intelligence has published a new report on the "Ankylosing Spondylitis Treatment Market" offering a comprehensive analysis of trends, growth drivers, and future projection

The Ankylosing Spondylitis (AS) Treatment Market is forecast to expand from approximately USD 7.15 billion in 2025 to about USD 10.39 billion in 2030, exhibiting a robust compound annual growth rate (CAGR) of 7.75% over the period. This projected growth is driven by a deeper understanding and recognition of axial spondylarthritis, the growing availability of MRI-based diagnostics augmented by artificial intelligence tools, wider reimbursement for both advanced biologics and biosimilars, and increasing pipeline activity for dual-target cytokine inhibitors. Access to oral Janus kinase (JAK) inhibitors is also helping expand treatment options beyond injectable drugs, while biosimilar competition is bringing down prices in mature markets.

Report Overview: https://www.mordorintelligence.com/industry-reports/ankylosing-spondylitis-treatment-market?utm_source=openpr

Key Trends

Rising recognition of axial spondyloarthritis
Increasing awareness and more precise diagnostic approaches are allowing patients to get identified and treated earlier.

AI-assisted diagnosis via MRI
Healthcare providers are leveraging artificial intelligence to help interpret MRI scans more quickly and accurately.

Growing reimbursement for biologics and biosimilars
Expanded payer coverage is making high-end biologic therapies more accessible to a broader patient population.

Emergence of dual cytokine inhibitors
New treatments targeting multiple inflammatory pathways are under development and are helping to broaden therapy choices.

Oral JAK inhibitors gaining traction
These non-injectable medications are being widely adopted thanks to patient preference for pill-based therapy.

Biosimilar competition improving affordability
The introduction of biosimilars is driving price competition, particularly in regions with established payer frameworks.

Algorithm-driven treat-to-target strategies
These approaches encourage more dynamic treatment adjustments, ultimately expanding the addressable market.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/ankylosing-spondylitis-treatment-market?utm_source=openpr

Market Segmentation

By Drug Class

NSAIDs

TNF Inhibitors

IL-17 Inhibitors

JAK Inhibitors

Biosimilars

Others

By Route of Administration

Oral

Sub-cutaneous

Intravenous

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Region:

North America

Europe

Asia‐Pacific

South America

Middle East & Africa

Explore Our Full Library of Healthcare Industry Research Reports

https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr

Key Players

Mordor Intelligence identifies several leading pharmaceutical companies in the Ankylosing Spondylitis Treatment Market, including-but not limited to:

Novartis AG

AbbVie Inc.

Amgen Inc.

Boehringer Ingelheim International GmbH

UCB S.A.

These organizations are expanding and competing through innovation in drug development, particularly around biosimilars and novel oral JAK inhibitors.

To know more about the major players in the market, visit: https://www.mordorintelligence.com/industry-reports/ankylosing-spondylitis-treatment-market/companies?utm_source=openpr

Conclusion

The Ankylosing Spondylitis Treatment Market is on a steady growth path, expected to rise from USD 7.15 billion in 2025 to USD 10.39 billion by 2030, with a 7.75% CAGR. This growth is supported by improved disease detection, reimbursement expansion, therapeutic innovation-including oral JAK inhibitors and dual cytokine-targeted therapies-and increasing competition via biosimilars.

North America currently sustains the largest share, driven by well-established healthcare infrastructure and early adoption of advanced treatments. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, thanks to specialist density growth and expanding hospital infrastructure.

For complete market analysis, visit the Mordor Intelligence page: https://www.mordorintelligence.com/industry-reports/ankylosing-spondylitis-treatment-market?utm_source=openpr

Industry Related Reports

Axial Spondyloarthritis (axSpA) Market: The Axial Spondyloarthritis (axSpA) Market is Segmented by Disease Types (Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis), by Drug Class (NSAIDs, Glucocorticoids, and More), Route of Administration (Oral, Subcutaneous, and More), Distribution Channel (Hospital Pharmacies, and More), and Geography (North America, Europe, Asia-Pacific, and More).

Get more insights: https://www.mordorintelligence.com/industry-reports/global-axial-spondyloarthritis-market?utm_source=openpr

Enbrel Market: The Enbrel Market Report is Segmented by Product Type, Application, and Geography. By Product Type is Segmented Into Branded Drugs, and Biosimilar Drugs. By Application is Divided Into Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, and Others. The Geography is Further Divided Into North America, Europe, Asia-Pacific, Middle East and Africa, and South America.

Get more insights: https://www.mordorintelligence.com/industry-reports/enbrel-market?utm_source=openpr

Osteonecrosis Treatment Market: The Osteonecrosis Treatment Market is Segmented by Treatment Type (Drugs and Bone Replacement Devices/Implants) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).

Get more insights: https://www.mordorintelligence.com/industry-reports/osteonecrosis-treatment-market?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ankylosing Spondylitis Treatment Market Projected to Reach USD 10.39 Billion by 2030, as Oral and Biosimilar Therapies Gain Traction here

News-ID: 4139125 • Views:

More Releases from Mordor Intelligence

Acupuncture Needles Market Forecasted to Reach USD 416.43 Million by 2030, Anchored by Aging Populations and E-Commerce Growth
Acupuncture Needles Market Forecasted to Reach USD 416.43 Million by 2030, Ancho …
Mordor Intelligence has published a new report on the "Acupuncture Needles Market" offering a comprehensive analysis of trends, growth drivers, and future projection The Acupuncture Needles Market is projected to expand from USD 302.04 million in 2025 to USD 416.43 million by 2030, reflecting a 6.63% compound annual growth rate (CAGR) over this period. Growth is underpinned by an aging global population seeking non-drug pain relief, growing clinical validation of
4D Printing in Healthcare Market Expected to Grow to USD 109.25 Billion by 2030, Driven by Materials Innovation and Asia-Pacific Expansion
4D Printing in Healthcare Market Expected to Grow to USD 109.25 Billion by 2030, …
Mordor Intelligence has published a new report on the "4D Printing in Healthcare Market" offering a comprehensive analysis of trends, growth drivers, and future projection. The 4D Printing in Healthcare Market is projected to expand from USD 34.83 billion in 2025 to USD 109.25 billion by 2030, reflecting an impressive compound annual growth rate of 25.69% over the forecast period. This sharp ascent comes as the healthcare sector increasingly turns to
Adeno-Associated Virus Vectors Manufacturing Market to Reach USD 2.79 Billion by 2030, Fueled by Cell-Line Shifts and Asia-Pacific Expansion
Adeno-Associated Virus Vectors Manufacturing Market to Reach USD 2.79 Billion by …
Mordor Intelligence has published a new report on the "Adeno-Associated Virus Vectors Manufacturing Market" offering a comprehensive analysis of trends, growth drivers, and future projection The Adeno-Associated Virus (AAV) Vectors Manufacturing Market is set to grow from USD 1.82 billion in 2025 to USD 2.79 billion by 2030, representing a solid CAGR of 8.9% as forecasted by Mordor Intelligence. This growth is propelled by expanding clinical adoption of in vivo
Acute Lymphocytic Leukemia Therapeutics Market Expected to Grow to USD 5.28 Billion by 2030, Driven by Targeted Therapy Expansion
Acute Lymphocytic Leukemia Therapeutics Market Expected to Grow to USD 5.28 Bill …
Mordor Intelligence has published a new report on the "Acute Lymphocytic Leukemia Therapeutics Market" offering a comprehensive analysis of trends, growth drivers, and future projection The Acute Lymphocytic Leukemia Therapeutics Market is projected to grow significantly, rising from USD 3.79 billion in 2025 to USD 5.28 billion by 2030, reflecting solid growth in treatment demand and innovation in therapies. This expansion stems from the increasing deployment of targeted therapies, particularly

All 5 Releases


More Releases for Treatment

Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any